
No transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2018-11-19 | Greg Gianforte | house | Sale | $15,001 - $50,000 |
No financial data available for MTZPY.
Company may not file with SEC or CIK is unresolved.
Mitsubishi Tanabe wins FDA approval for oral form of ALS drug
GlaxoSmithKline adjuvant used in world’s first plant-based COVID-19 shot
Zosano Pharma teams up with Mitsubishi Tanabe Pharma on patch-administered drug
Glaxo teams up with Medicago to develop COVID-19 vaccine
Akebia's Vadadustat OK'd in Japan for CKD anemia
Viela Bio inks deal with Mitsubishi Tanabe Pharma to develop inebilizumab in Asia
Mitsubishi Tanabe launches late-stage study in U.S. for continuous Parkinson's therapy
Bausch Health in-licenses autoimmune candidate from Mitsubishi Tanabe